1. Home
  2. CNDT vs KALV Comparison

CNDT vs KALV Comparison

Compare CNDT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$2.02

Market Cap

448.6M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.00

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
KALV
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.6M
551.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CNDT
KALV
Price
$2.02
$17.00
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$26.43
AVG Volume (30 Days)
1.2M
1.6M
Earning Date
11-07-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,072,000,000.00
$1,426,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.37
$204.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$7.30
52 Week High
$4.90
$17.28

Technical Indicators

Market Signals
Indicator
CNDT
KALV
Relative Strength Index (RSI) 48.34 70.46
Support Level $1.95 $15.88
Resistance Level $2.07 $17.10
Average True Range (ATR) 0.10 1.08
MACD 0.04 0.22
Stochastic Oscillator 68.75 96.52

Price Performance

Historical Comparison
CNDT
KALV

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: